BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15329914)

  • 1. An academic health center cost analysis of screening mammography: creating a financially viable service.
    Chen SL; Clark S; Pierce LJ; Hayes DF; Helvie MA; Greeno PL; Newman LA; Chang AE
    Cancer; 2004 Sep; 101(5):1043-50. PubMed ID: 15329914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening Mammography Program of British Columbia: pattern of use and health care system costs.
    Olivotto IA; Kan L; Mates D; King S
    CMAJ; 1999 Feb; 160(3):337-41. PubMed ID: 10065075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A workplace breast cancer screening program. Costs and components.
    Schrammel P; Griffiths RI; Griffiths CB
    AAOHN J; 1998 Nov; 46(11):523-9. PubMed ID: 9934000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.
    Ekwueme DU; Hall IJ; Richardson LC; Gardner JG; Royalty J; Thompson TD
    Cancer; 2008 Aug; 113(3):592-601. PubMed ID: 18536027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The costs of mammography screening in New Zealand: evidence from the pilot programmes.
    Menon A; Devlin NJ; Richardson AK
    N Z Med J; 1994 Dec; 107(991):501-3. PubMed ID: 7830979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
    Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
    Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the costs of mammographic screening program in the city of Florence].
    Spagnolo G; Zappa M; Paci E; Giorgi D; Rosselli del Turco M
    Epidemiol Prev; 1995 Dec; 19(65):330-7. PubMed ID: 8852082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Providing professional mammography services: financial analysis.
    Enzmann DR; Anglada PM; Haviley C; Venta LA
    Radiology; 2001 May; 219(2):467-73. PubMed ID: 11323474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counting the costs of mammography screening: first year results from the Sydney study.
    Gerard K; Salkeld G; Hall J
    Med J Aust; 1990 May; 152(9):466, 469-71. PubMed ID: 2381337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Economic evaluation of the new national breast cancer screening programme in France: application to the Bouche-du-Rhone district].
    Giorgi R; Reynaud J; Wait S; Seradour B
    Bull Cancer; 2005 Nov; 92(11):995-1001. PubMed ID: 16316834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost analysis of a mammographic screening program].
    Vanara F; Ponti A; Frigerio A; Segnan N
    Epidemiol Prev; 1995 Dec; 19(65):318-29. PubMed ID: 8852081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost of health care services provided to women enrolled in a community-based breast and cervical cancer screening program.
    Burack R; Latafa J
    J Health Care Poor Underserved; 2009 Aug; 20(3):713-20. PubMed ID: 19648699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mammography screening in Germany: how, when and why?].
    Bick U
    Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A screening mammography program. Staying alive and making it work.
    Monsees BS; Destouet JM
    Radiol Clin North Am; 1992 Jan; 30(1):211-9. PubMed ID: 1732928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
    Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
    J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing and testing a cost-assessment tool for cancer screening programs.
    Subramanian S; Ekwueme DU; Gardner JG; Trogdon J
    Am J Prev Med; 2009 Sep; 37(3):242-7. PubMed ID: 19666160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of alternative practices on the cost and quality of mammographic screening in the United States.
    Burnside E; Belkora J; Esserman L
    Clin Breast Cancer; 2001 Jul; 2(2):145-52. PubMed ID: 11899786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic value of orthopaedic trauma: the (second to) bottom line.
    Ziran BH; Barrette-Grischow MK; Marucci K
    J Orthop Trauma; 2008 Apr; 22(4):227-33. PubMed ID: 18404030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic analysis of outreach assessment clinics in breast screening programmes.
    van der Pol MM; Cairns JA; Gilbert FJ; Hendry PJ
    Int J Health Plann Manage; 1999; 14(1):57-67. PubMed ID: 10351680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.